Navigation Links
Endo Pharmaceuticals Reports Second Quarter Revenues and Updates Financial Guidance, Reflecting the Acquisition of American Medical Systems

t transactions as of August 9, 2011.About Endo Endo Pharmaceuticals is a U.S.-based, specialty healthcare solutions company with a diversified business model, operating in three key business segments – branded pharmaceuticals, generics and devices and services.  We deliver an innovative suite of complementary products and services to meet the needs of patients in areas such as pain management, pelvic health, urology, endocrinology and oncology. For more information about Endo Pharmaceuticals, and its wholly owned subsidiaries American Medical Systems, HealthTronics, Inc. and Qualitest Pharmaceuticals, please visit

(Tables Attached)The following tables present Endo's unaudited Net Revenues for the three and six months ended June 30, 2011 and 2010:

Endo Pharmaceuticals Holdings Inc.
Net Revenues (unaudited)
(in thousands)Three Months Ended

June 30Six Months Ended

June 302011


Percent Growth2011


Percent GrowthBranded PharmaceuticalsLIDODERM®$195,840




2%OPANA® ER92,853




67%Voltaren® Gel36,655
























28%FORTESTA™ Gel2,028


NMOther Branded Products(1)$   5,609

$  19,799

-72%$  12,579

$  39,056

-68%Royalty and Other Revenue3,751




22%Total B

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. ( Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
(Date:4/17/2015)... RALEIGH, N.C. , April 17, 2015 /PRNewswire/ ... of the Integrated Embolic Protection™ filter platform for ... completion of a $5.6 million Series B financing ... stage venture firm with a focus on medical ... medicine. The round also included Mountain Group Partners, ...
(Date:4/17/2015)... 2015 announces having ... on Global and China Lysine Industry to its ... and the deep research report in this field. ... information including definition, classification specifications, application, industry chain ... Europe , Japan ...
(Date:4/17/2015)... April 17, 2015 CVS Health Corporation (NYSE: ... on Friday, May 1, 2015, at 8:30 a.m. (EDT) ... financial results. An audio webcast of the ... Relations portion of the CVS Health website for all ... . This webcast will be archived and available on ...
Breaking Medicine Technology:Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 3Lysine Market International (US, Europe, Japan) Research Analysis 2Lysine Market International (US, Europe, Japan) Research Analysis 3Lysine Market International (US, Europe, Japan) Research Analysis 4Lysine Market International (US, Europe, Japan) Research Analysis 5
... 2011 ULURU Inc. (NYSE AMEX: ... of a portfolio of wound management and oral care products, ... NYSE Amex (the "Exchange"), dated December 5, 2011, indicating that ... granted the Company an extension until March 21, 2013 to ...
... CardioMEMS announced today that the U.S. Food and Drug ... the Champion Heart Failure Monitoring System, the first wireless, ... failure patients from their homes.  While the panel agreed ... of 9-1, the majority did not vote positively that ...
Cached Medicine Technology:ULURU Inc. Receives Notice From NYSE Amex Regarding Continued Listing Standards 2ULURU Inc. Receives Notice From NYSE Amex Regarding Continued Listing Standards 3FDA Advisory Panel Recommends Against Approval of Champion® Heart Failure Management System for Patients With Heart Failure 2FDA Advisory Panel Recommends Against Approval of Champion® Heart Failure Management System for Patients With Heart Failure 3
(Date:4/18/2015)... The Residential Senior Care Franchises ... years. The industry, which provides residential and personal-care services ... for themselves, has boomed on account of the aging ... seniors with memory impairment. As a result, IBISWorld expects ... 4.1% to $1.9 billion over the five years to ...
(Date:4/18/2015)... has released a new blog post explaining ... caused by a car accident. , Car insurance ... A policy can pay for car repairs and even ... carry appropriate coverage when they are driving. ... several important riders that offer extra coverage options. One ...
(Date:4/18/2015)... has released a new blog post explaining how ... protection against fire damage. , Clients can now find ... vehicle is set intentionally on fire. This type of damages ... other things. , It is possible to compare the ... , in just a few minutes. Clients should ...
(Date:4/18/2015)... PITTSBURGH, PA (PRWEB) April 18, 2015 ... so I decided to create a healthful juice ... an inventor from Rosedale, Md. "It increases my ... overall healthy body." , He developed Tapp's Juice ... The juice helps to prevent physical and mental ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 has ... online auto insurance quotes . , Clients ... a single website. The online environment provides important advantages ... vehicles. , Drivers who do not have coverage ... rates during any season, day or hour. Many agencies ...
Breaking Medicine News(10 mins):Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Auto Insurance Plans Can Cover Physical Injuries Caused By An Accident! 2Health News:Online Auto Insurance Quotes For Plans That Cover Fire Damages! 2Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2
... have poor functioning of a key heart measure may ... arteries.// ,The researchers looked specifically at how the ... the arteries, called endothelial functioning, affects the development of ... followed from childhood. Over the 21 years of the ...
... Prostate cancer is the most common cancer among men, affecting ... 220,000 new cases // of the disease are diagnosed every ... year. ,New research shows men who are diagnosed with ... a high risk of developing prostate cancer within one year. ...
... red wine each day could keep keep lung cancer away ... cancer and 187 patients requiring routine surgery between 1999 and ... early 60s. Patients were asked about their diet, smoking habits, ... each day. They were asked to specify if they drank ...
... New research shows that sleep disorders may be linked ... ADD ), // neuromuscular conditions, and psychiatric problems. ... patients with sleep apnea also had ADD. Results also ... insomnia. Further testing showed some of these patients also ...
... with uncontrolled asthma may be able to gain complete ... ,Researchers studied 3,416 patients with uncontrolled asthma. Some ... steroid for their asthma; some were on a low-dose ... steroid. Patients in all three subgroups were randomly assigned ...
... reduction surgery can successfully treat metabolic syndrome in most ... is a combination of conditions putting people at high ... is characterized by higher than normal blood sugar, high ... involved 645 patients who were treated for obesity with ...
Cached Medicine News:
... a 22 kD, 191 amino acid, polypeptide hormone ... pituitary. The hGH gene contains five exons and ... a gene family. The hGH ELISA is used ... into the cell culture supernatant of eukaryotic cells ...
... is a high-throughput immunoassay system built around ... 2000 with the important addition of Logic ... to be designed for optimal performance with ... for critical assays such as the cardiac ...
... IMMULITE 2000 assays ... with the IMMULITE 2000, ... access immunoassay analyzer. IMMULITE ... through centralization, and a ...
... and IMMULITE 1000 assays are ... IMMULITE and IMMULITE 1000, continuous ... offer simplicity in both design ... be found in a wide ...
Medicine Products: